RTF X: General Patient Access and CCIM

The primary goal is to discover potential biomarkers, which enables clinicians to predict the treatment success or typical comorbidities for the individual patients, to optimize the costs of the treatment, and to make better individualized treatment decisions.

 The unique features of the research area include the special access to the patients investigated, with the large number of doctors assigned and the long-term relationship with the CCIMs, which makes long-term observations possible at all, combined with the collection of high-quality clinical data and the findings from laboratory studies.

The members are searching for customized treatments with the earliest possible diagnosis. While doing so, they also maintain a special focus on comorbidities. The data they gain and the samples they collect enables them to facilitate efforts in other research areas, e.g. work on genetic risk profiles (RTF I), investigations of the microbiome (RTF II), possible output parameters (RTF VI) or research on non-genetic factors (nutrition, RTF V).

In RTF X there are close links between dermatology, rheumatology and gastroenterology. In addition, they collaborate with the various biobanks, the Centre for Clinical Studies (ZKS) and research areas RTF I-VII and RTF IX.